Work ScheduleStandard (Mon-Fri) Environmental ConditionsOffice Job Description Join Us as a Senior Country Approval Specialist - Make an Impact at the Forefront of Innovation The Senior Country Approval Specialist manages the preparation, review and coordination of
Country Study Startup Specialist (PART TIME) - Based in Bucharest - FSP Syneos Health® is a leading fully-integrated life sciences services organization built to accelerate customer success. We partner with innovators at every point across the drug development
About Protect Life Michigan Thousands of lives are on the line every day due to abortion. Are you ready to stand up and change hearts to stop it? We are defenders on a mission to recruit,
Hello, were Laka You might not have heard of us yet - thats OK, youve found us now - come and find out more about our journey. Founded in 2017, Laka set out to transform insurance
At Perrigo, we are driven by our mission to Makes Lives Better Through Trusted Health and Wellness Solutions, Accessible to All. We are proud to be a Top 10 player in the European Consumer Self-Care market
In a world of possibilities, pursue one with endless opportunities. Imagine Next! At Parsons, you can imagine a career where you thrive, work with exceptional people, and be yourself. Guided by our leadership vision of valuing
FLSA Status: Non-Exempt, Hourly Reports To: Project Manager Job Type: Full-Time, Regular Compensation: $40 - $50 per hour, based on relevant experience This position is based in the Midwest and offers flexibility to work remotely. Candidates must
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a
Bring more to life. Are you ready to accelerate your potential and make a real difference within life sciences, diagnostics and biotechnology? Within Danaher the work our diagnostic businesses do saves lives—and we’re all united by
The role – what you’ll do Barr is seeking a senior water resources consultant with a focus on mine water management to join our team as a mine water practice lead. In this hybrid role, you
Your opportunity By joining the Kardium team, you can help make a difference in the lives of millions around the world. We have developed a ground-breaking medical device for the diagnosis and treatment of the most
You could be the one who changes everything for our 28 million members as a clinical professional on our Medical Management/Health Services team. Centene is a diversified, national organization offering competitive benefits including a fresh perspective
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a
Your work will change lives. Including your own. The Impact You’ll Make Recursion is at the forefront of reimagining drug discovery and development through broadening the funnel of potential targets, using technology and standardization to build
What MatX Is Building MatXs mission is to make the world’s best AI models run as efficiently as allowed by physics, bringing the world years ahead in AI quality and availability. MatX is seeking System Software
FLSA Status: Exempt, Salary Reports To: Project Manager IV Job Type: Full-Time, Regular Compensation: $97,500 - $121,900 per year, based on relevant experience This position is based in the Midwest and offers flexibility to work remotely or